KaydedilenlerDerginizi ekleyin

Dergiler / art / 2014 / Cilt: 29 - Sayı: 1

Reactive arthritis following ıntravesical ınstillation of bacillus calmette-guerin

Selin HASSAN
Peyman YALÇIN
Şebnem ATAMAN
Nurban SÜLDÜR
Dergi
art
Sayfa
61–64
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response.
📊
Temel Bulgular & Veri:Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response.
💡
Sonuç & Katkı:In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Reactive arthritis is a seronegative, HLA-B27-linked spondyloarthropathy which occurs as a result of a pathogen, often of gastrointestinal or genitourinary origin, and triggers a cell-mediated immune response. In this article, we present a 64-year- old male case who developed reactive arthritis with fever and asymmetric oligoarthritis following treatment with intravesical Bacillus Calmette-Guerin (BCG) for bladder carcinoma.

🔖

Bu Makaleye Atıf Yap

HASSAN, S., YALÇIN, P., ATAMAN, Ş., SÜLDÜR, N. (2014). Reactive arthritis following ıntravesical ınstillation of bacillus calmette-guerin. art, Cilt: 29 - Sayı: 1, 61–64. https://ajindex.com/articles/351753

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Repo ML, Koivuniemi R, Breban M. Infections and arthritis. In. Bijlsma JWJ, editor. EULAR textbook on rheumatic diseases. 1st ed. London: BMJ Group; 2012. p. 335–6. 2 Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am 2006;20:827–47. 3. Harms RW, Berge KG, Hagen PT, Litin SC, Sheps SG. Reactive arthritis. Mayo Clinic [serial online] 2011. Accessed 06/06/2012. Available from: http://www. mayoclinic.com/health/reactive-arthritis/DS00486 4. Kim JY, Lee JH, Yoon IeN. Macular infarction associated with reactive arthritis. Korean J Ophthalmol 2010;24:310–3. 5. Alexandroff AB, Jackson AM, O’Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999;353:1689–94. 6. Librenjak D, Novaković ZS, Milostić K. Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up. Acta Clin Croat 2012;51:201–7. 7. Clavel G, Grados F, Lefauveau P, Fardellone P. Osteoarticular side effects of BCG therapy. Joint Bone Spine 2006;73:24–8. 8. Tinazzi E, Ficarra V, Simeoni S, Artibani W, Lunardi C. Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Rheumatol Int 2006;26:481–8. 9. Pardalidis NP, Papatsoris AG, Kosmaoglou EV, Georganas C. Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer. Clin Rheumatol 2002;21:536–7. 10. Carter JD. Treating reactive arthritis: insights for the clinician. Ther Adv Musculoskelet Dis 2010;2:45–54.